When medication fails to control paroxysmal atrial fibrillation—a type of irregular heartbeat that comes and goes—doctors often turn to a procedure called ablation to scar the heart tissue causing the problem. A new study directly compared two ways to do this: the newer pulsed field ablation (PFA) and the established radiofrequency ablation (RFA). The trial followed 289 patients across Europe for a year after their single procedure.
The key finding was that both methods were equally effective. About 77% of patients in each group were free from significant atrial arrhythmia recurrence after 12 months. The numbers were nearly identical: 112 out of 145 patients with PFA and 111 out of 143 with RFA. The statistical analysis confirmed there was no meaningful difference in success rates.
On safety, the study observed fewer serious procedure-related events with the newer PFA technique—3.4% versus 7.6% with RFA. However, this difference wasn't statistically significant, meaning it could be due to chance. The research, presented as a journal abstract, doesn't report on other adverse events or long-term outcomes beyond one year. While this adds evidence that PFA is a viable alternative, it doesn't establish superiority over the current standard approach.
